The invention relates to the compounds of formula I:
wherein one of X1 and X2 is MeSO2 and the other one is hydrogen or halogen and X3 is hydrogen or halogen. These compounds have been found to be useful in the prevention and the treatment of respiratory diseases, especially asthma, ARDS (Acute Respiratory Distress Syndrome), COPD (chronic obstructive pulmonary diseases), allergic rhinitis and related inflammatory conditions. More specifically, the invention relates to the use of said compound in the prevention and the treatment of asthma in steroid-resistant patients. The invention also relates to pharmaceutical formulations used in the treatment of said diseases.
该发明涉及式I的化合物:其中X1和X2中的一个是MeSO2,另一个是氢或卤素,X3是氢或卤素。已发现这些化合物在预防和治疗呼吸道疾病,特别是哮喘、ARDS(急性呼吸窘迫综合征)、
COPD(慢性阻塞性肺疾病)、过敏性鼻炎和相关炎症症状方面具有用途。更具体地,该发明涉及在类
固醇耐药患者中预防和治疗哮喘的所述化合物的使用。该发明还涉及用于治疗上述疾病的药物配方。